Summary
Arch Neurol. 2011 Apr;68(4):542; author reply 542-3. doi: 10.1001/archneurol.2011.57.
Targets of the peroxisome proliferator-activated receptor γ agonist trials for the prevention of Alzheimer disease.
Abstract:
日本語要旨:
AD治療薬としてのPPARγアゴニスト糖尿病薬チアゾリジンジオンの臨床治験
PMID: 21482939